E542-3374 Screening compound: N-[2-(2,5-dimethoxyphenyl)ethyl]-3-{1-[(2,5-dimethylphenyl)methyl]-1H-indol-3-yl}propanamide

E542-3374 Screening compound: N-[2-(2,5-dimethoxyphenyl)ethyl]-3-{1-[(2,5-dimethylphenyl)methyl]-1H-indol-3-yl}propanamide
E542-3374 Screening compound: N-[2-(2,5-dimethoxyphenyl)ethyl]-3-{1-[(2,5-dimethylphenyl)methyl]-1H-indol-3-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E542-3374
N-[2-(2,5-dimethoxyphenyl)ethyl]-3-{1-[(2,5-dimethylphenyl)methyl]-1H-indol-3-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E542-3374

Molecular Formula

C30H34N2O3 (C30 H34 N2 O3)

Compound Name

N-[2-(2,5-dimethoxyphenyl)ethyl]-3-{1-[(2,5-dimethylphenyl)methyl]-1H-indol-3-yl}propanamide

IUPAC name

N-[2-(25-dimethoxyphenyl)ethyl]-3-{1-[(25-dimethylphenyl)methyl]-1H-indol-3-yl}propanamide

SMILES

Cc1cc(Cn2c(cccc3)c3c(CCC(NCCc(cc(cc3)OC)c3OC)=O)c2)c(C)cc1

InChI

InChI=1S/C30H34N2O3/c1-21-9-10-22(2)25(17-21)20-32-19-24(27-7-5-6-8-28(27)32)11-14-30(33)31-16-15-23-18-26(34-3)12-13-29(23)35-4/h5-10,12-13,17-19H,11,14-16,20H2,1-4H3,(H,31,33)

InChI Key

HQHATGHGVBPBNX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14897736

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.61

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.062

Distribution Coefficient, logD

6.062

Water Solubility, LogSw

-5.53

Polar Surface Area

41.186

Acid Dissociation Constant (pKa)

13.97

Base Dissociation Constant (pKb)

4.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

E542-3374 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with E542-3374 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E542-3374?
Check Price and Availability of E542-3374, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E542-3374 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E542-3374
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E542-3374
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E542-3374 available by request